Hot Features
プレミアム
登録してリアルタイムのチャート、分析ツール、価格を入手してください。
Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...
Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...
Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...
Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis PR Newswire VICTORIA, BC, Nov. 12, 2024 One...
Eupraxia Pharmaceuticals Reports Third Quarter 2024 Financial Results PR Newswire VICTORIA, BC, Nov. 7, 2024 VICTORIA, BC, Nov. 7, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...
Eupraxia Pharmaceuticals Announces that it has Closed a Non-Brokered Private Placement of C$44.5 Million PR Newswire VICTORIA, BC, Oct. 31, 2024 VICTORIA, BC, Oct. 31, 2024 /PRNewswire/...
Eupraxia Pharmaceuticals to Present at American College of Gastroenterology Annual Scientific Meeting 2024 PR Newswire VICTORIA, BC, Oct. 28, 2024 VICTORIA, BC, Oct. 28, 2024 /PRNewswire/...
Lancet Rheumatology Publishes Phase 2b Data on Eupraxia Pharmaceuticals' EP-104IAR for the Treatment of Knee Osteoarthritis PR Newswire VICTORIA, BC, Oct. 15, 2024 Publication...
Eupraxia Pharmaceuticals to Present at United European Gastroenterology Week 2024 PR Newswire VICTORIA, BC, Oct. 10, 2024 VICTORIA, BC, Oct. 10, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc...
Eupraxia Pharmaceuticals Strengthens Senior Management Team PR Newswire VICTORIA, BC, Oct. 2, 2024 VICTORIA, BC, Oct. 2, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or...
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.39 | -8.14196242171 | 4.79 | 4.89 | 4.13 | 13500 | 4.61267252 | CS |
| 4 | 0.05 | 1.14942528736 | 4.35 | 5.45 | 3.89 | 28066 | 4.60491548 | CS |
| 12 | 0.99 | 29.0322580645 | 3.41 | 5.45 | 3.07 | 31971 | 4.12985925 | CS |
| 26 | 0.71 | 19.2411924119 | 3.69 | 5.45 | 3.07 | 23459 | 3.92079193 | CS |
| 52 | -1.42 | -24.3986254296 | 5.82 | 7.64 | 3.07 | 33049 | 4.34848298 | CS |
| 156 | 2.4 | 120 | 2 | 9.1 | 0.8 | 27709 | 4.25210602 | CS |
| 260 | -3.35 | -43.2258064516 | 7.75 | 9.1 | 0.8 | 25165 | 4.22878532 | CS |
RichieBoy
3分前
ducci1
5分前
powerbattles
5分前
sab63090
9分前
sab63090
12分前
sab63090
23分前
Fit Investment Ideas
23分前
GASMASK
26分前
LVerstee
33分前
oldmystic
38分前
Vexari
39分前
Quick12
39分前
xsxs
40分前
allezlOM
43分前
pauljon4
48分前
oldmystic
49分前
fade
49分前
manibiotech
52分前
Jefedejefes
1時間前
BeachBum
1時間前
BeachBum
1時間前
trader53
1時間前
zandant
1時間前
mc73
1時間前
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
